Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
Invasive candidiasis encompassing Candida bloodstream infections and deep-seated candidiasis can become a persistent health problem. These infections are caused by Candida species and have high morbidity and mortality rates. Species distribution, access to diagnosis, treatment and mortality are different around the world. The mortality rate is high in South America (30–70%), and Candida albicans is the most prevalent species in this region. However, a global epidemiological shift to non-albicans species has been observed. In this group, C. parapsilosis is the species most frequently detected, followed by C. tropicalis, and at a slower rate, C. glabrata, which has also increased, in addition to the emerging C. auris, resistance to several drugs. This article summarizes relevant aspects of candidemia pathogenesis, such as the mechanisms of fungal invasion, immune response, and the impact of genetic defects that increase host susceptibility to developing the infection. We also discuss relevant aspects of treatment and future challenges in South America.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Epidemiology of candidemia in South America (2017–2022). Data about C. auris were recently published by the Pan American Health Organization (PAHO) [28]. Species distribution might have changed since these data were collected.](https://figures.cochat.ai/paper-figures/3fd464907e0241f4a81809f061bfe290/invasive-candidiasis-update-and-current-challenges-in-the-management-of-this-figure-1.jpg)

![Figure 3 Invasive Candidiasis: Organs Susceptible of Infection by Candida spp. and Resulting Diseases. The names of diseases agree with those described by Pappas et al. [12].](https://figures.cochat.ai/paper-figures/a6bc7ef4e3a04307a25e0e5fe6a7e743/invasive-candidiasis-update-and-current-challenges-in-the-management-of-this-figure-3.jpg)
![Figure 4 Algorithm for management of Candida sepsis adapted from Keighley et al. and Thompson et al. [94,95].](https://figures.cochat.ai/paper-figures/9306af45413d483cb2762634c3142b37/invasive-candidiasis-update-and-current-challenges-in-the-management-of-this-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In South America, candidemia incidence ranges from 0.6–6.0 per 1000 hospital admission.48”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In South America, studies found that the mortality rate varies from 30–70%.48”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 3×
“Although current guidelines recommend therapy with FLZ AFST, not all patients are tested due to a lack of supplies in regional laboratories [86].”
BackgroundMethodPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793 · cited 3×
“Circulating cells such as neutrophils and resident macrophages act as effector cells in the control of fungal load through the production of metabolites such as H2O2, superoxide anion, nitric oxide (NO) and peroxide nitrites, which have a more powerful candidacidal activity compared to their progenitors [47,54].”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636 · cited 4×
“quickly to different parts of the world [12,26].”
BackgroundInfluentialGarcia-Vidal, C., Sanjuan, G., Moreno-García, E., Puerta-Alcalde, P., Garcia-Pouton, N., Chumbita, M., Fernandez-Pittol, M., Pitart, C., Inciarte, A., Bodro, M., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.041 · Cited by 1,022 · cited 1×
“7% (7/989) [35], Italy: 8% (3/43) [36], and the UK: 12.”
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845 · cited 1×
“Early identification of candidemia and treatment with appropriate antifungal drugs certainly reduce morbidity and mortality [81,82].”
BackgroundA Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800 · cited 1×
“in 2009 [71] in a large Iranian consanguineous family consisting of 43 members.”
Background
Cited by
El-Saadony, M. T., Saad, A. M., Mohammed, D. M., Korma, S. A., Alshahrani, M. Y., Ahmed, A. E., Ibrahim, E. H., Salem, H. M., Alkafaas, S. S., Saif, A. M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1491777 · Cited by 197
“Nosocomial infections may result from invasive candidiasis, or candidemia, which is the most prevalent opportunistic mycosis worldwide (151).”
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Saied, M., 亮, 前., Abdelghany, T. M., Amin, B. H., & 陽祐, 中. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124709 · Cited by 50
The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective
Ordaya, E. E., Clement, J., & Vergidis, P. I. (2023) · Mycopathologia · doi:10.1007/s11046-023-00759-5 · Cited by 45
“Compared to C. albicans isolates which commonly remain susceptible to fluconazole, non-albicans species demonstrate variable susceptibility to antifungal agents [7–9].”
BackgroundInfluentialYassin, M. T., Al-Otibi, F. O., Al-Askar, A. A., & Elmaghrabi, M. M. (2023) · Microorganisms · doi:10.3390/microorganisms11081957 · Cited by 37
“Candidemia continues to be a significant contributor to morbidity and mortality within healthcare environments [10].”
Background
Metadata
- Authors
- Riera, F. O., Caeiro, J. P., Angiolini, S. C., Vigezzi, C., Rodriguez, E., Icely, P. A., & Sotomayor, C. E.
- Affiliations
- Fundacion Allende (AR)
- Hospital Privado (AR)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Research Group of Immunology and Mycology, Córdoba 5000, Argentina
- Corresponding author
- Sotomayor, Claudia Elena
- ORCID
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2022-06-30
- Volume
- 11
- Issue
- 7
- Pages
- 877
- ISSN
- 2079-6382 (ISSN-L)
- PMC
- PMC9312041
- OpenAlex
- W4283760440
- Cited by
- 65
- References
- 103
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 16 · 2023: 19 · 2022: 6
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antibiotics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agencia Nacional de Promoción Científica y Tecnológica-FONCyT (PICT-2015-1393, 30720150100934CB, 33720180100058CB, PIP-112 201501-00652CO)
- SECyT-UNC (PICT-2015-1393, 30720150100934CB, 33720180100058CB, PIP-112 201501-00652CO)
- CONICET (PICT-2015-1393, 30720150100934CB, 33720180100058CB, PIP-112 201501-00652CO)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- invasive candidiasis, candidemia, Candida species distribution, non-albicans Candida, Candida parapsilosis, Candida tropicalis, Candida glabrata, Candida auris, antifungal resistance, host susceptibility, fungal pathogenesis, immune response, candidemia mortality, South America
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America. https://app.cochat.ai/papers/10.3390/antibiotics11070877
- The paper
- Riera, F. O., Caeiro, J. P., Angiolini, S. C., Vigezzi, C., Rodriguez, E., Icely, P. A., & Sotomayor, C. E. (2022). Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America. Antibiotics. https://doi.org/10.3390/antibiotics11070877
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.